Citation Impact
Citing Papers
Sustained hypoxia leads to the emergence of cells with enhanced growth, migratory, and promitogenic potentials within the distal pulmonary artery wall
2009
Tumor Angiogenesis Mediated by Myeloid Cells Is Negatively Regulated by CEACAM1
2012
GreenLight HPS laser 120‐W versus diode laser 200‐W vaporization of the prostate: Comparative clinical experience
2010
Late Outgrowth Endothelial Cells Resemble Mature Endothelial Cells and Are Not Derived from Bone Marrow
2012
Identification of Distinct Basal and Luminal Subtypes of Muscle-Invasive Bladder Cancer with Different Sensitivities to Frontline Chemotherapy
2014 Standout
Interdependency of CEACAM-1, -3, -6, and -8 induced human neutrophil adhesion to endothelial cells
2008
Hallmarks of Cancer: The Next Generation
2011 Standout
Lymph node density as a prognostic variable in node-positive bladder cancer: a meta-analysis
2015
Cancer treatment and survivorship statistics, 2022
2022 Standout
Systematic Review of Oncological Outcomes Following Surgical Management of Localised Renal Cancer
2012
Lymph Node Dissection Technique Is More Important Than Lymph Node Count in Identifying Nodal Metastases in Radical Cystectomy Patients: A Comparative Mapping Study
2011
EAU Guidelines on Non–Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016
2016 Standout
Systematic Review and Meta-analysis of Perioperative Outcomes and Complications After Robot-assisted Radical Prostatectomy
2012
Prospective single‐centre comparison of 120‐W diode‐pumped solid‐state high‐intensity system laser vaporization of the prostate and 200‐W high‐intensive diode‐laser ablation of the prostate for treating benign prostatic hyperplasia
2009
Upstaging of urothelial cancer at the time of radical cystectomy: factors associated with upstaging and its effect on outcome
2012
Urethral recurrence after radical cystectomy for urothelial carcinoma: A systematic review and meta-analysis
2017
Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2014 Standout
Defining the role of NMP22 in bladder cancer surveillance
2007
The Blood–Brain Barrier
2015 Standout
Mechanism and medical implications of mammalian autophagy
2018 Standout
Pathologic Downstaging Is a Surrogate Marker for Efficacy and Increased Survival Following Neoadjuvant Chemotherapy and Radical Cystectomy for Muscle-Invasive Urothelial Bladder Cancer
2011
Clinical development and potential of photothermal and photodynamic therapies for cancer
2020 Standout
Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study
2017 Standout
The Neurovascular Unit Coming of Age: A Journey through Neurovascular Coupling in Health and Disease
2017 Standout
Role of androgen receptor and associated lysine‐demethylase coregulators, LSD1 and JMJD2A, in localized and advanced human bladder cancer
2011
Discovery of Urinary Biomarkers
2006
Lymphangiogenesis: Molecular Mechanisms and Future Promise
2010 Standout
Systematic Review and Meta-analysis of Studies Reporting Oncologic Outcome After Robot-assisted Radical Prostatectomy
2012
Heme oxygenase-1 in neovascularisation: A diabetic perspective
2010
Screening for Bladder Cancer: Rationale, Limitations, Whom to Target, and Perspectives
2013
The value of extended transurethral resection of bladder tumour (TURBT) in the treatment of bladder cancer
2012
The biology and function of fibroblasts in cancer
2016 Standout
Systematic Review and Meta-analysis of Studies Reporting Urinary Continence Recovery After Robot-assisted Radical Prostatectomy
2012
Sex and Racial Disparities in the Treatment and Outcomes of Muscle-invasive Bladder Cancer
2020
ICUD-EAU International Consultation on Bladder Cancer 2012: Pathology
2012
A systematic review and meta-analysis on the oncological long-term outcomes after trimodality therapy and radical cystectomy with or without neoadjuvant chemotherapy for muscle-invasive bladder cancer
2017
Imaging angiogenesis of genitourinary tumors
2010
ICUD-EAU International Consultation on Bladder Cancer 2012: Radical Cystectomy and Bladder Preservation for Muscle-Invasive Urothelial Carcinoma of the Bladder
2012
Pericytes: Developmental, Physiological, and Pathological Perspectives, Problems, and Promises
2011 Standout
European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2020 Guidelines
2020 Standout
Bladder cancer biomarkers: current developments and future implementation
2007
Development, maintenance and disruption of the blood-brain barrier
2013 Standout
Bladder Cancer Incidence and Mortality: A Global Overview and Recent Trends
2016 Standout
Laser Treatment of Benign Prostatic Obstruction: Basics and Physical Differences
2011
EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2013 Guidelines
2013
The Impact of the Extent of Lymphadenectomy on Oncologic Outcomes in Patients Undergoing Radical Cystectomy for Bladder Cancer: A Systematic Review
2014
Critical Analysis of Bladder Sparing with Trimodal Therapy in Muscle-invasive Bladder Cancer: A Systematic Review
2014
Bladder cancer
2016 Standout
Diagnostic Efficacy of [11C]Choline Positron Emission Tomography/Computed Tomography Compared With Conventional Computed Tomography in Lymph Node Staging of Patients With Bladder Cancer Prior to Radical Cystectomy
2011
Updated 2016 EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer
2016 Standout
Preliminary results on selective light vaporization with the side-firing 980 nm diode laser in benign prostatic hyperplasia: an ejaculation sparing technique
2009
Exosomes – vesicular carriers for intercellular communication
2009 Standout
ICUD-EAU International Consultation on Bladder Cancer 2012: Screening, Diagnosis, and Molecular Markers
2012
Oncologic photodynamic therapy photosensitizers: A clinical review
2010
Seguimiento oncológico después de cistectomía radical basado en patrones de recidiva tumoral y sus factores de riesgo
2013
Emerging Biological Principles of Metastasis
2017 Standout
The meaning, the sense and the significance: translating the science of mesenchymal stem cells into medicine
2013 Standout
Radical Cystectomy for Urothelial Carcinoma of the Bladder Without Neoadjuvant or Adjuvant Therapy: Long-Term Results in 1100 Patients
2012
Systematic Review of Perioperative and Quality-of-life Outcomes Following Surgical Management of Localised Renal Cancer
2012
Targeting metastasis
2016
Bipolar Plasma Vaporization vs Monopolar and Bipolar TURP–A Prospective, Randomized, Long-term Comparison
2011
EAU Guidelines on the Treatment and Follow-up of Non-neurogenic Male Lower Urinary Tract Symptoms Including Benign Prostatic Obstruction
2013 Standout
Neutrophils, from Marrow to Microbes
2010 Standout
Recurrence and Progression of Disease in Non–Muscle-Invasive Bladder Cancer: From Epidemiology to Treatment Strategy
2009 Standout
Photodynamic therapy of cancer: An update
2011 Standout
The prognostic role of lymphovascular invasion in urothelial carcinoma of the bladder
2016
EAU Guidelines on Renal Cell Carcinoma: 2014 Update
2015 Standout
Nanomaterials for Photo-Based Diagnostic and Therapeutic Applications
2013
Gender and Bladder Cancer: A Collaborative Review of Etiology, Biology, and Outcomes
2015
Transurethral surgery and twice-daily radiation plus paclitaxel-cisplatin or fluorouracil-cisplatin with selective bladder preservation and adjuvant chemotherapy for patients with muscle invasive bladder cancer (RTOG 0233): a randomised multicentre phase 2 trial
2013
Best Practices in Robot-assisted Radical Cystectomy and Urinary Reconstruction: Recommendations of the Pasadena Consensus Panel
2015
The impact of female gender on bladder cancer-specific death risk after radical cystectomy: a meta-analysis of 27,912 patients
2015
Revisiting STAT3 signalling in cancer: new and unexpected biological functions
2014 Standout
Assessment of diagnostic gain with hexaminolevulinate (HAL) in the setting of newly diagnosed non–muscle-invasive bladder cancer with positive results on urine cytology
2014
Renal cell carcinoma
2017 Standout
A Contemporary Update on Pathology Standards for Bladder Cancer: Transurethral Resection and Radical Cystectomy Specimens
2012
Extended Versus Limited Lymph Node Dissection in Bladder Cancer Patients Undergoing Radical Cystectomy: Survival Results from a Prospective, Randomized Trial
2018
Regulatory networks defining EMT during cancer initiation and progression
2013 Standout
Prostate cancer invasion and metastasis: insights from mining genomic data
2013
EAU Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent—Update 2013
2013 Standout
Meta-analysis of Functional Outcomes and Complications Following Transurethral Procedures for Lower Urinary Tract Symptoms Resulting from Benign Prostatic Enlargement
2010
A new prognostic model for cancer‐specific survival after radical cystectomy including pretreatment thrombocytosis and standard pathological risk factors
2012
Follow-up After Surgical Treatment of Bladder Cancer: A Critical Analysis of the Literature
2012
Systematic Review and Cumulative Analysis of Oncologic and Functional Outcomes After Robot-assisted Radical Cystectomy
2015
Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): Explanation and Elaboration
2015 Standout
Fundamentals of cancer metabolism
2016 Standout
Extended vs non‐extended pelvic lymph node dissection and their influence on recurrence‐free survival in patients undergoing radical cystectomy for bladder cancer: a systematic review and meta‐analysis of comparative studies
2013
Clinical relevance of autophagic therapy in cancer: Investigating the current trends, challenges, and future prospects
2016
Bladder Cancer
2020 Standout
Adaptive and Maladaptive Cardiorespiratory Responses to Continuous and Intermittent Hypoxia Mediated by Hypoxia-Inducible Factors 1 and 2
2012 StandoutNobel
Nanotechnology for Multimodal Synergistic Cancer Therapy
2017 Standout
Nanoparticles in Photodynamic Therapy
2015 Standout
Follow-up after radical cystectomy based on patterns of tumor recurrence and its risk factors
2013
Inflammation induces lymphangiogenesis through up-regulation of VEGFR-3 mediated by NF-κB and Prox1
2009
The MicroRNA Spectrum in 12 Body Fluids
2010 Standout
Silver Nanoparticles: Synthesis, Characterization, Properties, Applications, and Therapeutic Approaches
2016 Standout
Cancer treatment and survivorship statistics, 2016
2016 Standout
Wound Healing: A Cellular Perspective
2018 Standout
BODIPY dyes in photodynamic therapy
2012 Standout
New photosensitizers for photodynamic therapy
2016 Standout
Robot‐assisted radical cystectomy
2015
Cancer treatment and survivorship statistics, 2019
2019 Standout
Endothelial Hypoxia-Inducible Factor-2α Is Required for the Maintenance of Airway Microvasculature
2019 StandoutNobel
Mechanisms of Diabetic Complications
2013 Standout
Photodynamic Therapy: Oncologic Horizons
2013
Bioorthogonal Labeling of Human Prostate Cancer Tissue Slice Cultures for Glycoproteomics
2017 StandoutNobel
Tumorigenicity of hypoxic respiring cancer cells revealed by a hypoxia–cell cycle dual reporter
2014
Neutrophil‐to‐lymphocyte ratio as a bladder cancer biomarker: Assessing prognostic and predictive value in SWOG 8710
2016
The diagnostic accuracy and cost-effectiveness of magnetic resonance spectroscopy and enhanced magnetic resonance imaging techniques in aiding the localisation of prostate abnormalities for biopsy: a systematic review and economic evaluation
2013
Pathologic Response Rates of Gemcitabine/Cisplatin versus Methotrexate/Vinblastine/Adriamycin/Cisplatin Neoadjuvant Chemotherapy for Muscle Invasive Urothelial Bladder Cancer
2013
Vascular Smooth Muscle Progenitor Cells
2011
Photopharmacology: Beyond Proof of Principle
2014 StandoutNobel
Photothermal Nanomaterials: A Powerful Light-to-Heat Converter
2023 Standout
Cancer treatment and survivorship statistics, 2014
2014 Standout
Initial Experiences with a 980 nm Diode Laser for Photoselective Vaporization of the Prostate for the Treatment of Benign Prostatic Hyperplasia
2011
Works of Derya Tilki being referenced
Tumor vessel stabilization and remodeling by anti-angiogenic therapy with bevacizumab
2011
Targeting autophagy overcomes Enzalutamide resistance in castration-resistant prostate cancer cells and improves therapeutic response in a xenograft model
2014
External Validation of Postoperative Nomograms for Prediction of All-Cause Mortality, Cancer-Specific Mortality, and Recurrence in Patients With Urothelial Carcinoma of the Bladder
2011
CEA-related cell adhesion molecule-1 is involved in angiogenic switch in prostate cancer
2006
Contrast-enhanced transrectal ultrasound (CE-TRUS) with cadence-contrast pulse sequence (CPS) technology for the identification of prostate cancer
2009
Validation of the AJCC TNM Substaging of pT2 Bladder Cancer: Deep Muscle Invasion Is Associated with Significantly Worse Outcome
2010
Urinary Cytology in Era of Fluorescence Endoscopy: Redefining the Role of an Established Method With a New Reference Standard
2010
EORTC Progression Score Identifies Patients at High Risk of Cancer-Specific Mortality After Radical Cystectomy for Secondary Muscle-Invasive Bladder Cancer
2013
Preliminary evaluation of a novel side‐fire diode laser emitting light at 940 nm, for the potential treatment of benign prostatic hyperplasia: ex‐vivo and in‐vivo investigations
2009
Validation of the Diagnostic Value of NMP22 ® BladderChek ® Test as a Marker for Bladder Cancer by Photodynamic Diagnosis
2006
Does the Extent of Lymphadenectomy in Radical Cystectomy for Bladder Cancer Influence Disease-Free Survival? A Prospective Single-Center Study
2011
Emerging biology of vascular wall progenitor cells in health and disease
2009
Individual Learning Curve Reduces the Clinical Value of Urinary Cytology
2011
Die Fluoreszenzzystoskopie beim Harnblasenkarzinom
2007
Lymphadenectomy for Bladder Cancer at the Time of Radical Cystectomy
2013
Plasma Vaporisation of the Prostate: Initial Clinical Results
2009
Urine Markers for Detection and Surveillance of Non–Muscle-Invasive Bladder Cancer
2011
Photodynamic Diagnosis of Prostate Cancer Using 5-Aminolevulinic Acid—First Clinical Experiences
2008
Stage‐dependent increase of orosomucoid and zinc‐alpha 2 ‐glycoprotein in urinary bladder cancer
2005
Photodynamic Therapy of Bladder Cancer – A Phase I Study Using Hexaminolevulinate (HAL)
2012
Multicenter evaluation of the prognostic value of pT0 stage after radical cystectomy due to urothelial carcinoma of the bladder
2011
Discrepancy between clinical and pathological stage: external validation of the impact on prognosis in an international radical cystectomy cohort
2011
Extent of lymph node dissection and recurrence-free survival after radical cystectomy: A meta-analysis
2014
Female Gender Is Associated With a Worse Survival After Radical Cystectomy for Urothelial Carcinoma of the Bladder: A Competing Risk Analysis
2014
Prognostic risk stratification of pathological stage T2N0 bladder cancer after radical cystectomy
2010
Quality of life and perioperative outcomes after retroperitoneoscopic radical nephrectomy (RN), open RN and nephron‐sparing surgery in patients with renal cell carcinoma
2009
Positive urine cytology but negative white‐light cystoscopy: an indication for fluorescence cystoscopy?
2008
Ex vivo and in vivo investigations of the novel 1,470 nm diode laser for potential treatment of benign prostatic enlargement
2008
The Diode Laser: A Novel Side-Firing Approach for Laser Vaporisation of the Human Prostate—Immediate Efficacy and 1-Year Follow-Up
2007
Critical analysis and validation of lymph node density as prognostic variable in urothelial carcinoma of bladder
2011
Vascular Wall as a Reservoir for Different Types of Stem and Progenitor Cells
2010
Optimizing Vesicourethral Anastomosis Healing After Robot-Assisted Laparoscopic Radical Prostatectomy: Lessons Learned from Three Techniques in 1900 Patients
2010
pT3 Substaging is a Prognostic Indicator for Lymph Node Negative Urothelial Carcinoma of the Bladder
2010
Lymphatic reprogramming of microvascular endothelial cells by CEA-related cell adhesion molecule-1 via interaction with VEGFR-3 and Prox1
2007
Soft Tissue Surgical Margin Status is a Powerful Predictor of Outcomes After Radical Cystectomy: A Multicenter Study of More Than 4,400 Patients
2010
Characteristics and Outcomes of Patients With Clinical Carcinoma In Situ Only Treated With Radical Cystectomy: An International Study of 243 Patients
2010
Potential implications of vascular wall resident endothelial progenitor cells
2007
Characteristics and Outcomes of Patients With pT4 Urothelial Carcinoma at Radical Cystectomy: A Retrospective International Study of 583 Patients
2009
Adjuvant cisplatin‐based combined chemotherapy for lymph node ( LN )‐positive urothelial carcinoma of the bladder ( UCB ) after radical cystectomy ( RC ): a retrospective international study of >1500 patients
2014
Urethral recurrence after cystectomy: current preventative measures, diagnosis and management
2015
Lymphovascular invasion is independently associated with bladder cancer recurrence and survival in patients with final stage T 1 disease and negative lymph nodes after radical cystectomy
2012
Prognostic Risk Stratification of Pathological Stage T3N0 Bladder Cancer After Radical Cystectomy
2011